Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 02:18PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-1.68 Insider Own16.90% Shs Outstand68.33M Perf Week-5.49%
Market Cap270.11M Forward P/E- EPS next Y-1.55 Insider Trans49.81% Shs Float65.25M Perf Month-19.06%
Income-124.58M PEG- EPS next Q-0.39 Inst Own55.84% Short Float5.27% Perf Quarter-30.85%
Sales0.00M P/S- EPS this Y6.30% Inst Trans-5.76% Short Ratio9.41 Perf Half Y63.81%
Book/sh2.01 P/B1.71 EPS next Y1.30% ROA-57.91% Short Interest3.44M Perf Year-50.14%
Cash/sh1.56 P/C2.21 EPS next 5Y- ROE-66.69% 52W Range1.66 - 7.19 Perf YTD6.17%
Dividend Est.- P/FCF- EPS past 5Y-27.43% ROI-75.28% 52W High-52.16% Beta2.49
Dividend TTM- Quick Ratio6.72 Sales past 5Y0.00% Gross Margin- 52W Low107.23% ATR (14)0.28
Dividend Ex-Date- Current Ratio6.72 EPS Y/Y TTM31.86% Oper. Margin0.00% RSI (14)33.36 Volatility4.90% 7.65%
Employees140 Debt/Eq0.07 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price19.29
Option/ShortYes / Yes LT Debt/Eq0.05 EPS Q/Q8.34% Payout- Rel Volume0.50 Prev Close3.74
Sales Surprise- EPS Surprise5.28% Sales Q/Q- EarningsMay 14 AMC Avg Volume365.38K Price3.44
SMA20-15.00% SMA50-19.99% SMA200-5.78% Trades Volume137,883 Change-8.02%
Date Action Analyst Rating Change Price Target Change
Jun-10-24Initiated William Blair Outperform
Nov-30-23Initiated Leerink Partners Outperform $7
Jun-15-22Initiated H.C. Wainwright Buy $25
May-16-24 12:21PM
May-15-24 07:00AM
May-14-24 10:54PM
May-12-24 03:26PM
05:00PM Loading…
May-02-24 05:00PM
Mar-26-24 07:19AM
Mar-20-24 05:32AM
Mar-18-24 10:53PM
Feb-29-24 03:02AM
Feb-27-24 04:30PM
Feb-26-24 09:55AM
09:55AM Loading…
Feb-09-24 09:55AM
Feb-08-24 08:00AM
Jan-26-24 12:00PM
Jan-03-24 08:30AM
Nov-21-23 04:30PM
Nov-08-23 04:05PM
Oct-26-23 08:30AM
Oct-09-23 08:30AM
Oct-05-23 08:30AM
Oct-02-23 05:30PM
Sep-21-23 04:05PM
Aug-31-23 04:05PM
Aug-09-23 04:05PM
Aug-02-23 04:05PM
May-30-23 09:06AM
09:55AM Loading…
May-15-23 09:55AM
May-11-23 08:50AM
May-10-23 04:19PM
May-03-23 08:00AM
May-02-23 07:50AM
Apr-25-23 06:35AM
Apr-23-23 04:02PM
Apr-21-23 04:05PM
Apr-20-23 02:46PM
Apr-19-23 11:36AM
Mar-08-23 04:01PM
Feb-07-23 05:17PM
Jan-26-23 12:00PM
Jan-09-23 07:00AM
Dec-21-22 06:12AM
Dec-07-22 04:30PM
Dec-02-22 06:36PM
Nov-28-22 08:30AM
Nov-24-22 05:54AM
Nov-23-22 09:00AM
Nov-21-22 05:45PM
Nov-17-22 12:39AM
Nov-16-22 04:01PM
Nov-10-22 04:05PM
Nov-04-22 08:00AM
Oct-14-22 06:12AM
Oct-04-22 08:30AM
Sep-29-22 08:00AM
Sep-26-22 09:21AM
Sep-15-22 09:39AM
Sep-06-22 04:05PM
Aug-16-22 09:55AM
Aug-10-22 04:01PM
Jul-06-22 02:00PM
Jun-16-22 08:00AM
May-20-22 08:30AM
May-11-22 04:09PM
May-07-22 09:38AM
May-03-22 08:00AM
Apr-28-22 08:00AM
Mar-24-22 08:30AM
Mar-23-22 04:05PM
Feb-08-22 12:01PM
Feb-04-22 01:03PM
Jan-31-22 08:00AM
Jan-10-22 08:00AM
Dec-23-21 12:38PM
Dec-22-21 04:05PM
Dec-17-21 10:06AM
Nov-22-21 08:00AM
Nov-19-21 08:00AM
Nov-10-21 04:05PM
Nov-05-21 08:36PM
Nov-03-21 03:41PM
Oct-12-21 06:05PM
Oct-08-21 12:42PM
Oct-04-21 10:54AM
Sep-30-21 06:02PM
Sep-08-21 04:00PM
Aug-31-21 08:00AM
Aug-03-21 04:05PM
Jul-30-21 05:28PM
Jul-29-21 11:46PM
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hoey TimothyChief Scientific OfficerMar 05 '24Sale7.003,30023,101245,346Mar 06 06:45 PM
Hoey TimothyChief Scientific OfficerFeb 20 '24Sale5.346,56935,046236,146Feb 21 06:05 PM
Tingley WhittemoreChief Medical OfficerFeb 16 '24Sale5.866,50038,09073,534Feb 16 08:35 PM
Ali FarazChief Executive OfficerFeb 16 '24Sale5.866,35837,258113,079Feb 16 08:30 PM
PATTERSON LEONE DChief Fin. and Bus. OfficerFeb 16 '24Sale5.865,20130,47860,755Feb 16 08:32 PM
Hoey TimothyChief Scientific OfficerFeb 16 '24Sale5.864,68127,431242,715Feb 16 08:37 PM
GOEDDEL DAVID VDirectorFeb 12 '24Buy4.502,222,2229,999,99913,599,275Feb 14 04:12 PM
COLUMN GROUP III GP, LP10% OwnerFeb 12 '24Buy4.502,222,2229,999,99913,599,275Feb 14 04:15 PM
Hoey TimothyChief Scientific OfficerAug 29 '23Sale4.267,24330,855247,396Aug 29 06:59 PM
Ali FarazChief Executive OfficerAug 16 '23Sale3.815,56321,195119,437Aug 18 06:31 PM
Tingley WhittemoreChief Medical OfficerAug 16 '23Sale3.815,56321,19576,437Aug 18 06:33 PM
PATTERSON LEONE DChief Fin. and Bus. OfficerAug 16 '23Sale3.814,45216,96264,542Aug 18 06:31 PM
Hoey TimothyChief Scientific OfficerAug 16 '23Sale3.814,00715,267254,639Aug 18 06:34 PM